Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 2003

View Archived Issues

AVI BioPharma plans second AVI-4020 study for West Nile virus

CytRx to fund UMMS research program of RNAi silencing for ALS

Investigator meeting precedes phase II study of ProCord

Doripenem similarly effective against ESBL- and non-ESBL-producing bacteria

New analgesic agents identified by Schwarz researchers

GSK antiangiogenic Tie-2 and/or VEGFR2 inhibitors covered by patent

Novel RT inhibitors prepared and tested at the U. of Pittsburgh and Fluorous Technologies

PPAR modulators and their use presented in recent patents

New Abeta production inhibitors/sAPPalpha secretion enhancers discovered at Takeda

U. of Tennessee team claims novel androgen receptor antagonists

Recombinant alpha1-antitrypsin enters proof-of-concept study for atopic dermatitis

Liprostin trial commences in Georgia

Proteasome inhibitor improves renovascular responses in hypercholesterolemic pigs

Thymitaq designated orphan drug in E.U. for liver cancer

License agreement for use of Amplivax in novel HIV vaccine candidate

Kyowa Hakko licenses KW-3902 rights to NovaCardia

Millennium commences phase I/II study of MLN-2704 in prostate cancer

Inspra approved for congestive heart failure in heart attack patients

Approvable letter for Savient's osteoarthritis pain product

YKP-1358 cleared to enter clinical testing

Bactericidal activity of oritavancin reported at IDSA meeting

Fast track status for TNX-355

Data discussed at IDSA support further development of dalbavancin

Safety and pharmacokinetics of single-dose oral glutamine in pediatric oncology patients

Darifenacin has beneficial effects in bladder function disorders

Good efficacy and tolerability described for solifenacin in overactive bladder patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...